# Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer

> **NCT00295867** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 45 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Zoledronic Acid

## Key facts

- **NCT ID:** NCT00295867
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11-03
- **Primary completion:** 2011-06
- **Final completion:** 2013-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2020-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00295867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00295867, "Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00295867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*